-
In this ‘Meet the CIDG staff’ feature we chat with Melissa Taylor, who joined the CIDG editorial base as a Research Assistant in November 2019. Melissa is authoring several qualitative evidence synthesis titles with the CIDG, including ‘Mass drug administration for filariasis: community views and programme design influences’ and ‘Community views...
April 13 2021
-
LSTM’s Centre for Evidence Synthesis in Global Health has led developments in systematic reviews in tropical medicine and international health. In the 1990s, staff contributed to setting up Cochrane, and established the Cochrane Infectious Diseases Group (CIDG). This is now recognised as one of Cochrane’s premier groups, with over 150...
April 8 2021
-
One new Cochrane protocol, one new Cochrane review, and two updated COVID-19 Cochrane reviews are in Issue 3, 2021 of the Cochrane Database of Systematic Reviews. New ProtocolMedley N, Taylor M, van Wyk SS, Oliver S. Community views on active case finding for tuberculosis in low‐ and...
April 1 2021
-
A new Cochrane editorial examines the 2020 story of chloroquine or hydroxychloroquine for treating COVID-19. Read the full Cochrane editorial here. During the past 12 months chloroquine and hydroxychloroquine have been touted as miracle cures for COVID‐19 and introduced into COVID‐19 treatment protocols in Asia, Africa, and North and...
March 26 2021
-
How accurate are rapid tests for diagnosing COVID‐19? What are rapid point‐of‐care tests for COVID‐19?Rapid point‐of‐care tests aim to confirm or rule out COVID‐19 infection in people with or without COVID‐19 symptoms. They:‐ are portable, so they can be used wherever the patient is (at the point of care);‐ are easy to perform, with a minimum...
March 24 2021
-
The Cochrane Library releases an updated Special Collection on diagnosing tuberculosisWorld Tuberculosis Day is marked annually on 24 March, and commemorates the date in 1882 when Dr Robert Koch announced his discovery of Mycobacterium tuberculosis, the bacillus that causes tuberculosis.This Special Collection, curated by Cochrane...
March 23 2021
-
How accurate are sputum Xpert tests for screening for active pulmonary tuberculosis and rifampicin resistance in adults whether or not they have tuberculosis symptoms?Why is using Xpert tests to screen for pulmonary tuberculosis important?Tuberculosis is the leading cause of infectious disease‐related death and one of the top 10 causes of death...
March 23 2021
-
Original version published on 30 September 2020.This is the second update of this review. The review authors included studies in people with suspected COVID-19 only, and excluded studies in people with confirmed COVID-19. The evidence is up to date to 30 September 2020. How accurate is chest imaging for diagnosing COVID‐19?Why is this...
March 17 2021
-
During May 2021, we have published 2 new Cochrane reviews and one Cochrane review update in Issue 5, 2021 of the Cochrane Database of Systematic Reviews. New reviewsHaraka F, Kakolwa M, Schumacher SG, Nathavitharana RR, Denkinger CM, Gagneux S, Reither K, Ross A. Impact of the diagnostic test Xpert MTB/RIF on patient outcomes for tuberculosis...
March 7 2021
-
One new COVID-19 review, one updated COVID-19 review, and one updated Cochrane review are in Issue 2, 2021 of the Cochrane Database of Systematic Reviews.New COVID 19 ReviewSingh B, Ryan H, Kredo T, Chaplin M, Fletcher T. Chloroquine or hydroxychloroquine for prevention and treatment of COVID‐19....
March 3 2021
LSTM’s Centre for Evidence Synthesis in Global Health has led developments in systematic reviews in tropical medicine and international health. In the 1990s, staff contributed to setting up Cochrane, and established the Cochrane Infectious Diseases Group (CIDG). This is now recognised as one of Cochrane’s premier groups, with over 150...April 8 2021
One new Cochrane protocol, one new Cochrane review, and two updated COVID-19 Cochrane reviews are in Issue 3, 2021 of the Cochrane Database of Systematic Reviews. New ProtocolMedley N, Taylor M, van Wyk SS, Oliver S. Community views on active case finding for tuberculosis in low‐ and...April 1 2021
A new Cochrane editorial examines the 2020 story of chloroquine or hydroxychloroquine for treating COVID-19. Read the full Cochrane editorial here. During the past 12 months chloroquine and hydroxychloroquine have been touted as miracle cures for COVID‐19 and introduced into COVID‐19 treatment protocols in Asia, Africa, and North and...March 26 2021
How accurate are rapid tests for diagnosing COVID‐19? What are rapid point‐of‐care tests for COVID‐19?Rapid point‐of‐care tests aim to confirm or rule out COVID‐19 infection in people with or without COVID‐19 symptoms. They:‐ are portable, so they can be used wherever the patient is (at the point of care);‐ are easy to perform, with a minimum...March 24 2021
How accurate are sputum Xpert tests for screening for active pulmonary tuberculosis and rifampicin resistance in adults whether or not they have tuberculosis symptoms?Why is using Xpert tests to screen for pulmonary tuberculosis important?Tuberculosis is the leading cause of infectious disease‐related death and one of the top 10 causes of death...March 23 2021
Original version published on 30 September 2020.This is the second update of this review. The review authors included studies in people with suspected COVID-19 only, and excluded studies in people with confirmed COVID-19. The evidence is up to date to 30 September 2020. How accurate is chest imaging for diagnosing COVID‐19?Why is this...March 17 2021
During May 2021, we have published 2 new Cochrane reviews and one Cochrane review update in Issue 5, 2021 of the Cochrane Database of Systematic Reviews. New reviewsHaraka F, Kakolwa M, Schumacher SG, Nathavitharana RR, Denkinger CM, Gagneux S, Reither K, Ross A. Impact of the diagnostic test Xpert MTB/RIF on patient outcomes for tuberculosis...March 7 2021
One new COVID-19 review, one updated COVID-19 review, and one updated Cochrane review are in Issue 2, 2021 of the Cochrane Database of Systematic Reviews.New COVID 19 ReviewSingh B, Ryan H, Kredo T, Chaplin M, Fletcher T. Chloroquine or hydroxychloroquine for prevention and treatment of COVID‐19....March 3 2021